{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T07:15:24Z","timestamp":1682320524825},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,4,19]],"date-time":"2005-04-19T00:00:00Z","timestamp":1113868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1007\/s00280-004-0954-3","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T12:39:11Z","timestamp":1113827951000},"page":"221-229","source":"Crossref","is-referenced-by-count":6,"title":["Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index"],"prefix":"10.1007","volume":"56","author":[{"given":"G\u00fcl","family":"\u00d6zcan Arican","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,4,19]]},"reference":[{"key":"954_CR1","first-page":"893","volume":"2","author":"JC Acosta","year":"2003","unstructured":"Acosta JC, Richard C, Delgado MD, Horita M, Rizzo MG, Fernandez-Luna JL, Leon J (2003) Amifostine impairs p53-mediated apoptosis of human myeloid leukemia cells. Mol Cancer Ther 2:893\u2013900","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"954_CR2","first-page":"1609","volume":"10","author":"B Brenner","year":"2003","unstructured":"Brenner B, Wasserman L, Beery E, Nordenberg J, Schechter J, Gutman H, Fenig E (2003) Variable cytotoxicity of amifostine in malignant and non-malignant cell lines. Oncol Rep 10(5):1609\u20131613","journal-title":"Oncol Rep"},{"issue":"2","key":"954_CR3","first-page":"85","volume":"85","author":"F Castiglione","year":"1999","unstructured":"Castiglione F, Dalla Mola A, Porcile G (1999) Protection of normal tissues from radiation and cytotoxic therapy: the development of amifostine. Tumori 85(2):85\u201391","journal-title":"Tumori"},{"key":"954_CR4","first-page":"1","volume":"296","author":"W Davis Jr","year":"2001","unstructured":"Davis W Jr, Ronai Z, Tew KD (2001) Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296:1\u20136","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"954_CR5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mrd.10087","volume":"62","author":"DG Matos de","year":"2002","unstructured":"de Matos DG, Herrera C, Cortvrindt R, Smitz J, Van Soom A, Nogueria D, Pasqualini RS (2002) Cysteamine supplementation during in vitro maturation and embryo culture: a useful tool for increasing the efficiency of bovine in vitro embryo production. Mol Reprod Dev 62(2):203\u2013209","journal-title":"Mol Reprod Dev"},{"issue":"4 Suppl 8","key":"954_CR6","first-page":"23","volume":"23","author":"RT Dorr","year":"1996","unstructured":"Dorr RT (1996) Cytoprotective agents for anthracyclines. Semin Oncol 23(4 Suppl 8):23\u201334","journal-title":"Semin Oncol"},{"key":"954_CR7","unstructured":"Freshney RI (1991) Disaggregation of the tissue and primary culture. In: Culture of animal cells. A manual of basic technique, 2nd edn. Wiley Liss, New York, pp 107\u2013126"},{"key":"954_CR8","unstructured":"Freshney RI (1991) Maintenance of the culture-cell lines. In: Culture of animal cells. A manual of basic technique, 2nd edn. Wiley Liss, New York, pp 127\u2013136"},{"issue":"1","key":"954_CR9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00001813-199701000-00004","volume":"8","author":"S Fulda","year":"1997","unstructured":"Fulda S, Oster W, Berthold F (1997) Effects of WR-2721 (amifostine) and its metabolite WR-1065 on the antiproliferative activity of chemotherapeutic agents on neuroblastoma cells in vitro. Anticancer Drugs 8(1):34\u201341","journal-title":"Anticancer Drugs"},{"issue":"10","key":"954_CR10","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1200\/JCO.1999.17.10.3038","volume":"17","author":"K Gelmon","year":"1999","unstructured":"Gelmon K, Eisenhauer E, Bryce C, Tolcher A, Mayer L, Tomlinson E, Zee B, Blackstein M, Tomiak E, Yau J, Batist G, Fisher B, Iglesias J (1999) Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer. J Clin Oncol 17(10):3038\u20133047","journal-title":"J Clin Oncol"},{"issue":"5","key":"954_CR11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0168-1702(84)90026-1","volume":"1","author":"JR Gentsch","year":"1984","unstructured":"Gentsch JR, Hatfield JW (1984) Saturable attachment sites for type 3 mammalian reovirus on murine L cells and human HeLa cells. Virus Res 1(5):401\u2013414","journal-title":"Virus Res"},{"key":"954_CR12","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/sj.bjc.6600779","volume":"88","author":"EJ Lee","year":"2003","unstructured":"Lee EJ, Gerhold M, Palmer MW, Christen RD (2003) p53 protein regulates the effects of amifostine on apoptosis, cell cycle progression, and cytoprotection. Br J Cancer 88:754\u2013759","journal-title":"Br J Cancer"},{"key":"954_CR13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00685842","volume":"32","author":"NM Lopes","year":"1993","unstructured":"Lopes NM, Adams EG, Pitts TW (1993) Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines. Cancer Chemother Pharmacol 32:235\u2013242","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"954_CR14","first-page":"257","volume":"22","author":"HG Modig","year":"1971","unstructured":"Modig HG, Edgren M, R\u00e9v\u00e9sz L (1971) Release of thiols from cellular mixed disulphides and its possible role in radiation protection. Int Radiat Biol 22(3):257\u2013268","journal-title":"Int Radiat Biol"},{"issue":"2","key":"954_CR15","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1006\/gyno.1999.5545","volume":"75","author":"TY Ng","year":"1999","unstructured":"Ng TY, Ngan HY, Cheng DK, Wong LC (1999) The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell lines. Gynecol Oncol 75(2):194\u2013197","journal-title":"Gynecol Oncol"},{"issue":"10","key":"954_CR16","first-page":"2484","volume":"25","author":"S Obata","year":"1990","unstructured":"Obata S, Yamaguchi Y, Miyamoto T (1990) Effects of etoposide (VP-16) on the survival and progression of cultured HeLa S3 cells through the cell cycle. Nippon Gan Chiryo Gakkai Shi 25(10):2484\u20132491","journal-title":"Nippon Gan Chiryo Gakkai Shi"},{"issue":"1","key":"954_CR17","first-page":"23","volume":"16","author":"FG \u00d6zcan","year":"1997","unstructured":"\u00d6zcan FG, Top\u010dul MR, Y\u0131lmazer N, R\u0131dvano\u011fullar\u0131 M (1997) Effect of epirubicin on 3H-thymidine labelling index in cultured L-strain cells. J Exp Clin Cancer Res 16(1):23\u201327","journal-title":"J Exp Clin Cancer Res"},{"issue":"4 Suppl 8","key":"954_CR18","first-page":"35","volume":"23","author":"GD Paine","year":"1996","unstructured":"Paine GD, Taylor CW, Lopez MH, Johnson CS, Capizzi RL (1996) Effects of amifostine and paclitaxel on growth of human ovary carcinoma xenografts in the severe combined immune-deficiency mouse: preliminary results. Semin Oncol 23(4 Suppl 8):35\u201339","journal-title":"Semin Oncol"},{"issue":"2","key":"954_CR19","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2307\/3575142","volume":"77","author":"JW Purdie","year":"1979","unstructured":"Purdie JW (1979) A comparative study of the radioprotective effects of cysteamine, WR-2721 and WR-1065 in cultured human cells. Radiat Res 77(2):303\u2013311","journal-title":"Radiat Res"},{"key":"954_CR20","first-page":"646","volume":"19","author":"EK Rowinsky","year":"1992","unstructured":"Rowinsky EK, Onetto N, Canetta RM, Arbuck SG (1992) Taxol: the first of the taxanes, an important new class of antitumor agents. Semin Oncol 19:646\u2013662","journal-title":"Semin Oncol"},{"issue":"11","key":"954_CR21","first-page":"1035","volume":"84","author":"V Santini","year":"1999","unstructured":"Santini V, Giles FJ (1999) The potential of amifostine: from cytoprotectant to therapeutic agent. Haematologica 84(11):1035\u20131042","journal-title":"Haematologica"},{"key":"954_CR22","unstructured":"Shannon JE (1972) The American Type Culture Collection. Registry of animal cell lines, vol 301. ATCC, Rockville, pp 881\u20132600"},{"issue":"3","key":"954_CR23","first-page":"1067","volume":"297","author":"H Shen","year":"2001","unstructured":"Shen H, Chen Z, Zilfou JT, Hopper E, Murphy M, Tew KD (2001) Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs. Pharmacology 297(3):1067\u20131073","journal-title":"Pharmacology"},{"issue":"6","key":"954_CR24","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2165\/00003495-199550060-00008","volume":"50","author":"CM Spencer","year":"1995","unstructured":"Spencer CM, Goa KL (1995) Amifostine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as a radioprotector and cytotoxic chemoprotector. Drugs 50(6):1001\u20131031","journal-title":"Drugs"},{"issue":"2","key":"954_CR25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1095\/biolreprod49.2.228","volume":"49","author":"M Takahashi","year":"1993","unstructured":"Takahashi M, Nagai T, Hamano S, Kuwayama M, Okamura N, Okano A (1993) Effect of thiol compounds on in vitro development and intracellular glutathione content of bovine embryos. Biol Reprod 49(2):228\u2013232","journal-title":"Biol Reprod"},{"issue":"10","key":"954_CR26","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0959-8049(97)00221-9","volume":"33","author":"CW Taylor","year":"1997","unstructured":"Taylor CW, Wang LM, List AF, Fernandes D, Paine-Murrieta GD, Johnson CS, Capizzi RL (1997) Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumor cells is maintained. Eur J Cancer 33(10):1693\u20131698","journal-title":"Eur J Cancer"},{"issue":"11","key":"954_CR27","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1210\/mend.15.11.0729","volume":"15","author":"Z Wang","year":"2001","unstructured":"Wang Z, Yu R, Melmed S (2001) Mice lacking pituitary tumor transforming gene show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, and premature centromere division. Mol Endocrinol 15(11):1870\u20131879","journal-title":"Mol Endocrinol"},{"key":"954_CR28","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0360-3016(92)90719-X","volume":"24","author":"X Zhang","year":"1992","unstructured":"Zhang X, Lai PP, Taylor YC (1992) Differential radioprotection of cultured human diploid fibroblasts and fibrosarcoma cells by WR-1065. Int J Radiat Oncol Biol Phys 24:713\u2013719","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0954-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-004-0954-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-004-0954-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T10:06:11Z","timestamp":1559037971000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-004-0954-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4,19]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["954"],"URL":"https:\/\/doi.org\/10.1007\/s00280-004-0954-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,4,19]]}}}